Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Hezbollah rockets hit 165 UNIFIL positions in Lebanon while targeting Israel, IDF reveals - 27 Logically Demonstrated Techniques for Better Rest
- 3'Always put others first': IDF reservist who died while on leave saves four with organ transplants
- 4South Korea to End Bear Bile Farming and Find New Homes for the 200 Bears Stuck in the Industry
- 5Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
- Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- Iran Used $2 Billion in Crypto to Run Its Militant Proxies in 2025
- Figure out How to Streamline Your Profits in Gold Speculation
- Inside Plan with Houseplants: An Aide
- Winter storm warnings issued across Northeast as up to 9 inches of snow forecast; deadly atmospheric river in California snarls travel
- Looter indicted after pretending to be emergency worker at Dimona rocket crash site
- Purchases of iPhone 17 Pro soar across Gaza amid 'limited' humanitarian aid
- Rediscovering Experience Through Excursions: Individual Travel Stories
- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
